Insider Holders & Insider Ownership - INCYTE CORP (INCY)

List of insiders holdings for INCYTE CORP:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
14159 capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner
2017-02-22 16:47:0134,389,438
0
34,389,438Form 13D
Baker Brothers Life Sciences Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner
2017-02-22 16:47:0134,389,438
0
34,389,438Form 13D
Baker Bros. Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner
2017-02-22 16:47:0134,389,438
0
34,389,438Form 13D
Baker / Tisch Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner
2017-02-22 16:47:0134,389,438
0
34,389,438Form 13D
Baker Biotech Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner
2017-02-22 16:47:0134,389,438
0
34,389,438Form 13D
BAKER BROS. ADVISORS LP
14159 L.P.
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director
10% Owner
2024-06-14 18:23:0531,209,896
0
31,209,896Form 13D
BAKER BROS. ADVISORS LP
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director
10% Owner
2024-10-02 16:11:45559,963
28,217,048
28,777,011Form 4
BAKER BIOTECH CAPITAL II GP LLC
BAKER FELIX
BAKER JULIAN
10% Owner
2009-03-02 17:05:3618,593,196
0
18,593,196Form 13D
TISCH ANDREW H
No longer 10% owner.
2005-02-10 11:31:031,541,669
0
1,541,669Form 13G
TISCH THOMAS J
No longer 10% owner.
2004-08-13 15:58:35117,592
1,416,661
1,534,253Form 4/A
TISCH JAMES S
No longer 10% owner.
2004-08-13 15:58:06117,592
1,216,661
1,334,253Form 4/A
TISCH DANIEL R
No longer 10% owner.
2006-04-21 12:04:181,126,669
0
1,126,669Form 13G
WHITFIELD ROY A
Director
2014-01-17 16:19:51662,832
0
662,832Form 5
Hoppenot Herve
Chairman / CEO
2024-07-17 12:27:28557,863
0
557,863Form 4
FRIEDMAN PAUL A
Director
2020-05-28 16:27:11267,327
15,000
282,327Form 4
CAGNONI PABLO J
President, R&D
2024-07-17 12:28:04265,581
0
265,581Form 4
BROOKE PAUL A
Director
2020-04-02 17:01:14221,911
40,000
261,911Form 4
HASTINGS DAVID C
Chief Financial Officer
2014-06-06 18:47:53227,470
0
227,470Form 4
Stamoulis Christiana
EVP & Chief Financial Officer
2024-07-17 12:25:00123,324
0
123,324Form 4
Wenqing Yao
EVP, Head of Discovery Chem
2021-07-07 17:54:42113,629
0
113,629Form 4
SWAIN PAULA J
EVP, Human Resources
2024-07-17 12:29:58102,360
0
102,360Form 4
KELLER JOHN A
Chief Business Officer
2008-02-11 17:28:56100,000
0
100,000Form 4
Andrews Patricia S
Chief Commercial Officer
2012-01-23 16:43:17100,000
0
100,000Form 4
DE SCHUTTER RICHARD U
Chairman
2015-03-09 16:35:2199,821
0
99,821Form 4
Stein Steven H
EVP & Chief Medical Officer
2024-08-14 15:37:1790,011
0
90,011Form 4
Pasquale Maria E
EVP & General Counsel
2023-07-18 16:00:1589,999
0
89,999Form 4
SAXE JON S
Director
2004-04-01 14:08:0580,000
0
80,000Form 4
Dhanak Dashyant
EVP & Chief Scientific Officer
2023-07-18 16:00:1875,864
0
75,864Form 4
Morrissey Michael James
EVP, Head of Tech. Operations
2024-01-24 14:15:1372,300
0
72,300Form 4
Daly James M
EVP, Chief Commercial Officer
2015-06-25 16:28:0571,283
0
71,283Form 4
METCALF BRIAN W
Chief Drug Discovery Scientist
2011-04-13 16:09:0166,504
0
66,504Form 4
Flannelly Barry P
EVP & General Manager US
2024-11-08 12:48:5958,042
0
58,042Form 4
ARIKO BARRY A
Director
2015-03-13 16:28:0245,834
0
45,834Form 4
HURLEY SCOTT W
VP/Corp Controller & Treasurer
2005-01-27 12:58:5940,000
0
40,000Form 4
Iyengar Vijay K
EVP, GMAPPS
2024-07-29 15:50:2736,701
0
36,701Form 4
Dickinson Jonathan Elliott
EVP, General Manager, Europe
2024-09-16 13:24:1736,390
0
36,390Form 4
Huber Reid M
EVP, Chief Scientific Officer
2018-07-18 16:28:2634,571
0
34,571Form 4
FBB Associates
Director
10% Owner
2012-06-18 17:33:5633,410
0
33,410Form 3
BIENAIME JEAN JACQUES
Director
2024-06-14 12:17:2130,840
0
30,840Form 4
Denton Sheila A.
EVP & General Counsel
2024-10-04 12:39:5530,343
0
30,343Form 4
FOUSE JACQUALYN A
Director
2024-06-14 12:16:4929,325
0
29,325Form 4
Heeson Lee
EVP, Head of Incyte Intl
2024-10-03 13:28:0826,447
0
26,447Form 4
Tray Thomas
Principal Accounting Officer
2024-09-16 13:25:1324,443
0
24,443Form 4
High Katherine A
Director
2024-06-14 12:16:1923,340
0
23,340Form 4
SCHRECK PATRICIA A
EVP, General Counsel
2011-05-11 16:17:5322,276
0
22,276Form 4
BRAWLEY OTIS W
Director
2024-06-14 12:15:4321,251
0
21,251Form 4
Siegel Eric H.
EVP, General Counsel
2017-09-15 16:28:3321,053
0
21,053Form 4
CRAVES FRED B
Director
2005-06-03 09:43:5120,000
0
20,000Form 4
Emmens Matthew
Director
2008-05-22 16:32:4320,000
0
20,000Form 4
NIBLACK JOHN F
Director
2011-05-23 16:38:4120,000
0
20,000Form 4
Levy Richard S
EVP, Chief Drug Dev Officer
2016-01-08 16:37:5619,802
0
19,802Form 4
Clancy Paul J
Director
2024-10-02 13:01:2619,382
0
19,382Form 4
Schaffert Susanne
Director
2024-06-14 12:15:0018,237
0
18,237Form 4
DIXON WENDY L
Director
2022-04-04 16:00:3217,768
0
17,768Form 4
HARRIGAN EDMUND
Director
2024-10-02 13:00:5116,732
0
16,732Form 4
Trotta Matteo
EVP, GM, Dermatology US
2024-07-17 12:28:4116,395
0
16,395Form 4
Chardonnet Laurent
Vice President and Treasurer
2015-04-01 16:27:3815,129
0
15,129Form 4
FBB2 LLC
Director
10% Owner
2012-06-18 17:35:4815,110
0
15,110Form 3
Friedman Steven M.
EVP, Biology & Preclinical Dev
2010-05-20 16:11:5515,000
0
15,000Form 4
GRYSKA DAVID W
Executive Vice President, CFO
2018-07-18 16:12:4110,235
0
10,235Form 4
Trower Paul
Principal Accounting Officer
2022-01-21 16:37:503,250
0
3,250Form 4
TISCH BONNIE J
10% Owner
2004-01-16 16:57:590
0
0Form 4
PLATINUM ASSET MANAGEMENT LTD
10% Owner
2009-02-10 18:56:090
0
0Form 13G
DAMIAL FOUNDATION INC
10% Owner
2004-02-13 19:51:280
0
0Form 4